Recombinant Human RUNX3 protein (His tag)

A DNA sequence encoding the Human RUNX3 protein (Q13761) (Met 1-Tyr 415) was expressed with a N-His tag.

Introducing the Recombinant Human RUNX3 Protein (HIS TAG), a cutting-edge product meticulously engineered to cater to the diverse needs of the scientific community. This protein, derived from human sources, has been synthesized using advanced recombinant technology, ensuring utmost purity and quality.

The Recombinant Human RUNX3 Protein (HIS TAG) boasts a highly specific and efficient binding capacity, making it an invaluable tool for various research applications. Its unique HIS TAG feature enables facile purification and detection, simplifying experimental procedures and enhancing overall productivity.

With its exceptional stability and solubility, this protein offers unparalleled reliability and reproducibility, guaranteeing consistent results across experiments. Its robust nature allows for extended storage without compromising its integrity, ensuring long-term usability and convenience.

The Recombinant Human RUNX3 Protein (HIS TAG) is meticulously manufactured in compliance with stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to ensure optimal performance and reliability, providing researchers with the utmost confidence in their experimental outcomes.

This product is designed to empower scientists and researchers in their quest for groundbreaking discoveries and advancements in various fields, including molecular biology, genetics, and oncology. Its versatility and efficacy make it an indispensable asset in elucidating the intricate mechanisms underlying cellular processes and disease pathogenesis.

In summary, the Recombinant Human RUNX3 Protein (HIS TAG) is a state-of-the-art scientific tool that combines unrivaled purity, efficiency, and reliability. With its exceptional features and uncompromising quality, this protein is poised to revolutionize research endeavors, propelling scientific innovation to new heights.